FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Kevin Myers

Research Profile

Chemicals & Drugs

Living Beings

Procedures

Concepts & Ideas

Anatomy

Placenta

Co-author Network

Publications

TOP 3
Richard Harrop; Matthew G Ryan; Kevin A Myers; Irina Redchenko; Susan M Kingsman; Miles W Carroll
Active treatment of murine tumors with a highly attenuated vaccinia virus expressing the tumor associated antigen 5T4 (TroVax) is CD4+ T cell dependent and antibody mediated.
Richard Harrop; Noel Connolly; Irina Redchenko; Juan Valle; Mark Saunders; Matthew G Ryan; Kevin A Myers; Noel Drury; Susan M Kingsman; Robert E Hawkins; Miles W Carroll
Vaccination of colorectal cancer patients with modified vaccinia Ankara delivering the tumor antigen 5T4 (TroVax) induces immune responses which correlate with disease control: a phase I/II trial.
A Lamikanra; Kevin A Myers; N Ferris; K A Mitrophanous; Miles W Carroll
In vivo evaluation of an EIAV vector for the systemic genetic delivery of therapeutic antibodies.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Kevin Myers (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2006: Richard Harrop; Matthew G Ryan; Kevin A Myers; Irina Redchenko; Susan M Kingsman; Miles W Carroll
Active treatment of murine tumors with a highly attenuated vaccinia virus expressing the tumor associated antigen 5T4 (TroVax) is CD4+ T cell dependent and antibody mediated.
Cancer immunology, immunotherapy : CII 2006;55(9):1081-90.
2006: Richard Harrop; Noel Connolly; Irina Redchenko; Juan Valle; Mark Saunders; Matthew G Ryan; Kevin A Myers; Noel Drury; Susan M Kingsman; Robert E Hawkins; Miles W Carroll
Vaccination of colorectal cancer patients with modified vaccinia Ankara delivering the tumor antigen 5T4 (TroVax) induces immune responses which correlate with disease control: a phase I/II trial.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(11 Pt 1):3416-24.
2005: A Lamikanra; Kevin A Myers; N Ferris; K A Mitrophanous; Miles W Carroll
In vivo evaluation of an EIAV vector for the systemic genetic delivery of therapeutic antibodies.
Gene therapy 2005;12(12):988-98.
2002: Kevin A Myers; Matthew G Ryan; Peter L Stern; David M Shaw; M Jim Embleton; Susan M Kingsman; Miles W Carroll
Targeting immune effector molecules to human tumor cells through genetic delivery of 5T4-specific scFv fusion proteins.
Cancer gene therapy 2002;9(11):884-96.
2002: Kate Mulryan; Matthew G Ryan; Kevin A Myers; David Shaw; Who Wang; Susan M Kingsman; Peter L Stern; Miles W Carroll
Attenuated recombinant vaccinia virus expressing oncofetal antigen (tumor-associated antigen) 5T4 induces active therapy of established tumors.
Molecular cancer therapeutics 2002;1(12):1129-37.
2002: David M Shaw; Andrew M Woods; Kevin A Myers; Caroline Westwater; Veena Rahi-Saund; Michael J Davies; David V Renouf; Elizabeth F Hounsell; Peter L Stern
Glycosylation and epitope mapping of the 5T4 glycoprotein oncofoetal antigen.
The Biochemical journal 2002;363(Pt 1):137-45.
2000: David M Shaw; M Jim Embleton; Caroline Westwater; Matthew G Ryan; Kevin A Myers; Susan M Kingsman; Miles W Carroll; Peter L Stern
Isolation of a high affinity scFv from a monoclonal antibody recognising the oncofoetal antigen 5T4.
Biochimica et biophysica acta 2000;1524(2-3):238-46.
1999: K W King; F C Sheppard; Caroline Westwater; Peter L Stern; Kevin A Myers
Organisation of the mouse and human 5T4 oncofoetal leucine-rich glycoprotein genes and expression in foetal and adult murine tissues.
Biochimica et biophysica acta 1999;1445(3):257-70.